Login    Join free Add to favorites    中文
home > news > Vaccine Development and Manufacturing Forum 2017锛圛nnoVax Forum锛
Industry Updates | New Products | Supplier News | Upcoming Events | business | web
Vaccine Development and Manufacturing Forum 2017锛圛nnoVax Forum锛

hits:1062     Date:08/04/17

InnoVax Forum (Vaccine Development and Manufacturing Forum 2017

Event Date: Nov.15-16, 2017
Event Venue: Shanghai, PR. China
Event Website: www.innovaxsummit.com
2017 Key Discussions
Overview and Trends for Vaccine Industry and Product Development
China/Asian Vaccine R&D and Industry Outlook
Quality Control and Manufacturing Excellence for Vaccine Products towards Global Market
New Technologies for Vaccine Research and Antigen Discovery
Modern Vaccine Design for the Improved Efficacy, Safety and Production
Vaccine Adjuvant Technology and Therapeutic Vaccine Development
Viral Challenge Studies and Animal Model
Vaccine Clinical Development, Safety Evaluation and Immunogenicity Assessment
Novel Vaccine Delivery System and Formulation
Innovation in Vaccine Process Development and Manufacturing
New/Alternative Manufacturing Platform for Vaccine Production
Single-use Systems, Multiple Products Facility and Flexible Manufacturing
Analytical Characterization, Control and Purification Development
Quality by Design, High-throughput Vaccine Process Development
Keynote Speakers & Presentations
Margaret Liu, Principal, ProTherImmune; President of International Society for Vaccines
Session 1: The Future Landscape of Vaccine Product Development
Session 2: Emerging Infectious Disease and the role of Gene-based Vaccine
Ken Ishii, Director, Center for Vaccine and Adjuvant Research, NIBIOHN, Professor, Osaka University
Session Topic: Cutting-edge Science towards Next Generation Adjuvant and Immunotherapeutic Agent
Sha Ha, Director, Vaccine BioProcess R&D, Merck & Co. USA
Session Topic: Evaluation of antibody quality elicited by a replication defective HCMV vaccine
Partial Speakers Committee:
Prof. Honghai Wang, Director of Academia Committee of Shanghai Key Laboratory of TB, Fudan University
Charles Sia, Chief Technical Officer, Vaccine R&D, BravoVax Bio
Pele Chong, Senior VP, Vaccine R&D, United Biomedical Taiwan
Jung-Sun Yum, Executive Director, R&D Centre, Korea CHA Vaccine Institute
Fengcai Zhu, Vice Director, Professor, Jiangsu Center for Disease Prevention and Control
Yen-Hung Chow, Associate Principal Investigator, National Taiwan Health Research Institutes
Xia Jin, Distinguished Professor and Principal Investigator, Institute Pasteur of Shanghai, Chinese Academy of Sciences
Sean Du, Head of External R&D Asia Pacific, Global R&D, Sanofi Pasteur
David Shao, Chief Financial Officer, Yisheng Bio
Harry Pan, R&D Director, Xiamen InnoVax Biotech
Prof. Yue-chun Kim, Assistant Professor, Korea Advanced Institute of Science and Technology
Prof. Ze Chen, Professor, Shanghai Institute of Biological Products
Tao Peng, Chief Scientific Officer, Guangdong South China United Vaccine institute
This forum also provides certain complimentary passes to professionals from vaccine manufacturers (with no products currently licensed/marketed) and research institutes. Seats are limited. Please contact the committee for the latest availability and suitability.
For more information on agenda, speaking, exhibiting and supporting opportunities, please contact:
Wei Zhang
Program Manager
Organizing Committee
InnoVax Forum: Vaccine Development and Manufacturing Forum 2017
Tel: 86.21.6034.0229
Related News>> more

Copyright(C) 2006-2018 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙